Ameriprise’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
AIC
ACM
Ameriprise's SOPH Position: Q3 2026 in Review
Ameriprise increased its SOPHiA GENETICS (SOPH) stake by 28% in Q3 2026, buying an estimated $4.42M and bringing the position to 2,831,050 shares worth $23.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1374.
Ameriprise first reported a position in SOPH in Q2 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.
- Ameriprise held 2,831,050 shares of SOPHiA GENETICS worth $23.7M as of Q3 2026.
- Ameriprise bought 614,298 SOPHiA GENETICS shares in Q3 2026, an estimated $4.42M.
- SOPHiA GENETICS made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #1374 holding.
- Ameriprise first reported a position in SOPHiA GENETICS in Q2 2026 and has held it in 2 quarters since.
- 93 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.